Schedule 13G ownership disclosure
Benitec Biopharma Inc
Common Stock, par value $0.0001 · CUSIP: 08205P209
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Franklin Resources, Inc.
Shares: 4,493,691.00 · Class: 18.1%
- Charles B. Johnson
Shares: 0.00 · Class: 0%
- Rupert H. Johnson, Jr.
Shares: 0.00 · Class: 0%
- Franklin Advisers, Inc.
Shares: 4,493,691.00 · Class: 18.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000038777-25-000005
- Form type
- SCHEDULE 13G/A
- Filer
- Benitec Biopharma Inc.
- CIK
- CIK 1808898
- Filed
- Jan 27, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership